2011 Q2/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +25 Siegfried AG
8.4
2 -1 Cilag AG
8.3
3 +0 Lumavita AG
8.1
4 +2 Nycomed Pharma AG
8.1
5 -1 Newron
8.0
6 +1 Axentis Pharma AG
8.0
7 -5 Actelion Ltd.
7.8
8 -3 Medinova AG
7.8
9 +9 4-Antibody AG
7.6
10 +55 Nycomed International Management GmbH
7.5
11 -3 Neurimmune Therapeutics AG
7.2
12 +26 Vifor (International) Ltd.
7.0
13 +26 Helvepharm AG
7.0
14 -5 Antares Pharma AG
6.9
15 +15 Kuros Biosurgery AG
6.9
16 +57 F. Hoffmann-La Roche AG (Worldwide)
6.9
17 -5 Pharmakon Ltd.
6.8
18 -4 Med Discovery S.A.
6.8
19 +59 MEDA Pharma GmbH
6.7
20 -4 Pentapharm (DSM Nutritional Products AG)
6.7
21 -4 BioPartners GmbH
6.7
22 -11 Takeda Pharma AG
6.7
23 +53 Tillotts Pharma AG
6.6
24 -14 ArisGen SA
6.5
25 -10 Neurotune
6.3
26 -2 Tricom GmbH, Pharma Division
6.3
27 -2 GlaxoSmithKline AG
6.3
28 -7 AmVac AG
6.3
29 -2 Auris Medical AG
6.2
30 -10 OMIDA AG
6.2
31 +3 GKL Biotec AG
6.2
32 -3 Molecular Partners
6.2
33 -14 Dr. Wild & Co. AG
6.1
34 -3 Virbac Schweiz AG
6.1
35 -3 Cytos Biotechnology AG
6.0
36 -1 Octapharma AG
5.9
37 -1 Lipideon Biotechnology AG
5.9
38 -10 Max Zeller Söhne AG
5.9
39 -2 Biogen Idec International GmbH
5.8
40 -17 Johnson & Johnson Pharmaceutical Research & Development
5.7
41 +6 Anavex Life Sciences Corp.
5.6
42 +14 Acino Holding AG
5.6
43 +1 A. Menarini AG
5.6
44 +1 Sanofi-Aventis
5.6
45 +4 Bristol-Myers Squibb SA
5.5
46 +4 BioVersys GmbH
5.5
47 +12 Debiopharm S.A.
5.4
48 -8 Novartis International AG
5.4
49 -16 Teva Pharma AG
5.3
50 +5 Novelty Pharma Galenical Development and Documentation
5.3


Changes in rank are compared to 2011 Q1/Global Life Sciences. Since then, 3 sites entered the survey and 10 sites could not be included in the rankings (2 fewer since last time). Build your own. Report statistics.